SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, Ayelet Keren‐Naus, Liora Boehm-Cohen, Yael Raviv, Yonat Shemer‐Avni, Elli Rosenberg, Ran Taube
Topics & Concepts
NeutralizationInfectivityVirologyBiologyVaccinationAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)TiterNeutralizing antibodySpike ProteinCoronavirus disease 2019 (COVID-19)VirusImmunologyMedicineDiseaseInfectious disease (medical specialty)PathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing